Disposition of 17802 shares by Weinhoff Gregory M of Centessa Pharmaceuticals at 12.2903 subject to Rule 16b-3

CNTA Stock  USD 17.60  0.30  1.73%   
About 58% of all Centessa Pharmaceuticals' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Centessa Pharmaceuticals PLC suggests that some traders are interested. The current market sentiment, together with Centessa Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Centessa Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Centessa Pharmaceuticals PLC Officer: Chief Business Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 17802 ordinary shares at 12.2903 of Centessa Pharmaceuticals by Weinhoff Gregory M on 23rd of August 2024. This event was filed by Centessa Pharmaceuticals PLC with SEC on 2024-08-23. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Centessa Pharmaceuticals' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Centessa Pharmaceuticals' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Centessa Pharmaceuticals Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Centessa Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Centessa Pharmaceuticals Fundamental Analysis

We analyze Centessa Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Centessa Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Centessa Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Working Capital

Working Capital Comparative Analysis

Centessa Pharmaceuticals is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Centessa Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Centessa Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Centessa Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Centessa Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Centessa Pharmaceuticals Related Equities

IPSCCentury Therapeutics   20.74   
0%
100.0%
CCCCC4 Therapeutics   8.59   
0%
41.0%
LRMRLarimar Therapeutics   7.44   
0%
35.0%
GLUEMonte Rosa   5.93   
0%
28.0%
ERASErasca   5.04   
0%
24.0%
MLYSMineralys Therapeutics,   4.71   
0%
22.0%
STROSutro Biopharma   3.46   
0%
16.0%
IRONDisc Medicine   3.03   
0%
14.0%
CGEMCullinan Oncology   2.51   
0%
12.0%
TARSTarsus Pharmaceuticals   2.38   
0%
11.0%
TRDAEntrada Therapeutics   2.37   
0%
11.0%
OPTOpthea   1.83   
0%
8.0%
NAMSWNewAmsterdam Pharma   1.68   
0%
8.0%
CRNXCrinetics Pharmaceuticals   1.59   
0%
7.0%
GNFTGenfit   0.95   
0%
4.0%
HLVXHillevax   0.52   
0%
2.0%
NUVLNuvalent   0.48   
0%
2.0%
EWTXEdgewise Therapeutics   0.37   
0%
1.0%
DSGNDesign Therapeutics   2.93   
14.0%
0%

Complementary Tools for Centessa Stock analysis

When running Centessa Pharmaceuticals' price analysis, check to measure Centessa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Centessa Pharmaceuticals is operating at the current time. Most of Centessa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Centessa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Centessa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Centessa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Share Portfolio
Track or share privately all of your investments from the convenience of any device